Tuberculosis in patients with systemic lupus erythematosus-a 37-year longitudinal survey-based study.
X XiaoG DaX XieX LiuL ZhangB ZhouH LiP LiH YangH ChenYunyun FeiG C TsokosL ZhaoXuan ZhangPublished in: Journal of internal medicine (2020)
Systemic lupus erythematosus patients treated vigorously with GC/ISA should be alerted of increased risk of TB infection, especially miliary and intracranial TB. Positive T-SPOT.TB and lymphocytopenia served as discriminatory variables between SLE/TB + and SLE/TB- patients. Lymphocytopenia was associated with poorer outcomes in SLE/TB + patients.
Keyphrases
- systemic lupus erythematosus
- mycobacterium tuberculosis
- end stage renal disease
- disease activity
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- emergency department
- rheumatoid arthritis
- peritoneal dialysis
- type diabetes
- patient reported outcomes
- metabolic syndrome
- insulin resistance
- hiv aids
- skeletal muscle
- glycemic control
- solid phase extraction